BIOMESENSE, INC.
GutLab hardware device for standardized microbiome sample collection paired with MetaBiome bioinformatics platform for microbiome data analysis
- Sector
- Biotech
- Headquarters
- CHICAGO, IL
- Founded
- 2018
- Latest Form D
- $7.1M, Nov 2025
- Total capital
- $19.5M
- Federal grants
- $3.8M
- 6 awards · 2021–2026
- Rank in peer group#10 of 18
- Private capital raised
- $15.7M
- 3 Form D · last Nov 2025
- 12 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 8 pending · first 2022
- Rank in peer group#8 of 18
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome$677K
- Private capital raisedForm D · SEC · 3rd filing$7.1M
- Federal grantHealth and Human S · Phase II · Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome$1.1M
- Federal grantNSF · Phase II · SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome$1.2M
- Private capital raisedForm D · SEC · 2nd filing$6.2M
- Federal grantHealth and Human S · Phase I · Development of a Novel Biosensor to AccelerateInvestigations of the Gut Microbiome.$294K
- Federal grantHealth and Human S · Phase I · Development of a Novel Biosensor to AccelerateInvestigations of the Gut Microbiome.$294K
- Private capital raisedForm D · SEC · 1st filing$2.4M
Show 1 earlier federal award
- Federal grantNSF · Phase I · SBIR Phase I: Development of a Novel Biosensor to Accelerate Investigations of COVID-19 and the Gut Microbiome.$256K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 18 peers
Line = medianBiotech · Device
- Federal grantsBelow median
- Granted patents#8 · top 44%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Dylan NicholsResearcherDirectorLinked by $3.8M in grants as PI
- Andrew BluesteinDirectorNamed in SEC Form D filings
- Ashley HartmanDirectorNamed in SEC Form D filings
- Kevin HonakerExecutive Officer, DirectorNamed in SEC Form D filings
- Orhan ErtughrulDirectorNamed in SEC Form D filings
- Parikshit SharmaDirectorNamed in SEC Form D filings
Show all 7 people
- Vanessa Rollings GiannisDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 9- PendingSystems And Methods For Processing Stool SamplesUSPTOApplication 18328429
- GrantedDevice And Method For Stool Sample CollectionUSPTOUS 11,375,986
- PendingSystems And Methods For Processing Stool SamplesUSPTOApplication 17552702
Show all 9 patent records
- Systems And Methods For Processing Stool SamplesApr 4, 2024 · Application 18328429Pending
- Device And Method For Stool Sample CollectionJul 5, 2022 · US 11,375,986Granted
- Systems And Methods For Processing Stool SamplesJun 2, 2022 · Application 17552702Pending
- Systems And Methods For Stool Sample CollectionDec 24, 2020 · Application 16902795Pending
- Systems And Methods For Processing Stool SamplesApplication 62864419Pending
- Systems And Methods For Stool Sample CollectionApplication 62864266Pending
- Systems And Methods For Processing Stool SamplesApplication PCTUS2021063379Pending
- Systems And Methods For Processing Stool SamplesApplication 63125816Pending
- Systems And Methods For Processing Stool SamplesApplication PCTUS2020038563Pending
Related companies, and why
- BIOMESENSE INCShares a founder: DYLAN NICHOLS
- Optimeos Life Sciences, Inc.Similar federal contract value in Biotech · null in contracts
- SYGNAMAP, INC.Similar federal contract value in Biotech · null in contracts
- Antheia, Inc.Similar federal contract value in Biotech · null in contracts
- PUMPKINSEED TECHNOLOGIES INCSimilar federal contract value in Biotech · null in contracts
- AnkyrBio LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .